WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.

被引：0
|
作者：
Faderl, S [1 ]
Estrov, Z [1 ]
Kantarjian, HM [1 ]
Fokt, I [1 ]
Harris, D [1 ]
Van, X [1 ]
Priebe, Q [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
278
引用
收藏
页码：65A / 65A
页数：1
相关论文
共 23 条
  • [1] WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity
    Faderl, S
    Estrov, Z
    Kantarjian, HM
    Harris, D
    Van, Q
    Fokt, I
    Przewloka, T
    Godlewski, C
    Woynarowski, JM
    Priebe, W
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3777 - 3784
  • [2] WP744 is a novel anthracycline with enhanced activity against neuroblastoma
    Inge, TH
    Harris, NL
    Wu, JQ
    Azizkhan, RG
    Priebe, W
    JOURNAL OF SURGICAL RESEARCH, 2004, 121 (02) : 187 - 196
  • [3] WP744, a novel anthracycline highly active against STI-571-resistant tumors
    Priebe, W
    Evrony, G
    Lee, S
    Fokt, I
    Talpaz, M
    Donato, N
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S126 - S126
  • [4] Practical synthesis of WP744, a brain tumor-targeting anthracycline.
    Fokt, ID
    Kowalczyk-Przewoka, T
    Skora, S
    Kosior, M
    Pastuch, G
    Wandzik, I
    Grynkiewicz, G
    Szeja, W
    Priebe, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U226 - U226
  • [5] Synthesis of WP744, a novel highly apoptotic anticancer agent.
    Fokt, ID
    Priebe, W
    Grynkiewicz, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U211 - U211
  • [6] Preclinical pharmacokinetics of WP744, a novel promising anticancer agent.
    Madden, T
    Scholz, CR
    Thapar, N
    Johansen, MJ
    Culotta, K
    Fokt, I
    Priebe, W
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6264S - 6264S
  • [7] WP-10349 a novel Jak-Stat inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML)
    Faderl, S
    Ferrajoli, A
    Harris, D
    Van, Q
    Priebe, W
    Estrov, Z
    ANTICANCER RESEARCH, 2005, 25 (3B) : 1841 - 1850
  • [8] A sensitive and specific method for the determination of WP744, a mechanistically altered anthracycline in mouse, rat, dog, and human plasma by LC/MS/MS.
    Scholz, CR
    Thapar, N
    Johansen, MJ
    Pang, J
    Fokt, I
    Culotta, K
    Priebe, W
    Timothy, M
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6262S - 6262S
  • [9] Novel anthracycline oligosaccharides: Influence of chemical modifications of the carbohydrate moiety on biological activity.
    Cipollone, A
    Berettoni, M
    Binaschi, M
    Cermele, C
    Olivieri, L
    Palomba, D
    Salvatore, C
    Goso, C
    Maggi, CA
    Animati, F
    CLINICAL CANCER RESEARCH, 2000, 6 : 4531S - 4531S
  • [10] WP-1034, a novel Jak-Stat inhibitor, has proapoptotic and antileukemic activity in acute myeloid leukemia (AML) cell lines and AML patient samples.
    Faderl, S
    Ferrajoli, A
    Harris, D
    Van, Q
    Priebe, W
    Estrov, Z
    BLOOD, 2004, 104 (11) : 693A - 693A
123